Lifestyle Intervention to Improve Muscle Function in Older Adults

May 14, 2026 updated by: Candida Rebello, Pennington Biomedical Research Center
The goal of this randomized controlled two-arm trial is to determine the effect of a diet and exercise intervention for 12 weeks on body composition, muscle function, and energy balance in 80 adults aged 50 years and over with obesity and insulin resistance. The main questions the trial aims to answer are: Will 12 weeks of a structured nutrition plan + exercise reduce fat mass, improve muscle function, and increase energy deficit compared to the usual diet + exercise. The hypothesis is that 12 weeks of a structured nutrition plan + exercise will reduce fat mass, improve muscle function, and produce greater energy deficit than the usual diet + exercise. Participants will be provided with all meals for 12 weeks and will exercise at the Center under supervision three times each week. Pre and post-intervention, body composition, physical function, and energy deficit will be measured.

Study Overview

Detailed Description

In the United States nearly one third of adults over 60 years of age have sarcopenic obesity which encompasses the combined effect of muscle impairment and obesity. A strategy that addresses the combined effect of muscle impairment and obesity while modulating muscle mass and composition is an unanswered challenge. This 12-week study will evaluate the effects of a structured nutrition plan combined with an exercise program on body fat and muscle mass, lower-extremity function (Short Physical Performance Battery), muscle strength (handgrip and knee strength), and daily caloric intake. The study will enroll adults aged 50 years and older with obesity (body mass index ≥ 30 kg/m²) and insulin resistance as indicated by a homeostasis model assessment of insulin resistance (HOMA-IR) score ≥ 3. Subjects will be randomly allocated to receive the structured nutrition plan and exercise intervention or to their usual diet and exercise in equal numbers (40 per group). The study will enrich our understanding of the physiological adaptations necessary for effective lifestyle interventions to improve muscle function.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Louisiana
      • Baton Rouge, Louisiana, United States, 70808
        • Pennington Biomedical Research Center
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Age > 50 years.
  2. Body mass index (BMI) ≥ 30 kg/m2.
  3. Homeostatic model assessment of insulin resistance ≥ 3.
  4. Mini-Mental State Examination (MMSE) > 25.
  5. Geriatric Depression Scale-15 (GDS-15) < 9.
  6. Sedentary (less than 90 minutes/week of moderate to vigorous activity).
  7. Ability to provide written informed consent.

Exclusion Criteria:

  1. Diagnosis of cancer (received within five years) or diabetes (type 1 and 2), or significant musculoskeletal, or cardiovascular, or hepatic, or renal, disease or dysfunction.
  2. Clinically significant gastrointestinal malabsorption syndromes such as chronic diarrhea, celiac disease, or clinically significant abnormal laboratory markers.
  3. Fluctuation in body weight > 3 kg in the preceding two months
  4. Condition that impedes testing of the study hypothesis or makes it unsafe to exercise or consume the study foods.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Structured nutrition plan + exercise
Intervention: Participants receive a structured nutrition plan, and exercise under supervision.
Participants will receive a structured nutrition plan. The exercise intervention will be the same in both groups.
Active Comparator: Typical or usual diet + exercise
Participants receive a typical or usual diet, and exercise under supervision
Participants will receive a diet representing the usual diet in this population. The exercise intervention will be the same in both groups.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fat mass
Time Frame: Change from baseline to 12 weeks
Fat mass measured by dual X-ray absorptiometry
Change from baseline to 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skeletal muscle mass
Time Frame: Change in from baseline to 12 weeks
Skeletal muscle mass will be measured by the creatine methyl D-3 dilution method
Change in from baseline to 12 weeks
Short physical performance battery
Time Frame: Change from baseline to 12 weeks
A test of physical function
Change from baseline to 12 weeks
Hand-grip strength
Time Frame: Change from baseline to 12 weeks
Hand grip strength will be measured using a hand dynamometer
Change from baseline to 12 weeks
Knee strength
Time Frame: Change from baseline to12 weeks
Knee strength will be measured quantified using Biodex dynamometry
Change from baseline to12 weeks
Energy stores
Time Frame: 12 weeks
Change in energy stores/day (kcal) determined from measures of body composition using the energy balance method
12 weeks
Hormonal regulation of energy balance
Time Frame: Change from baseline to 12 weeks
Blood concentrations of glucagon-like peptide 1
Change from baseline to 12 weeks
Hormonal regulation of energy balance
Time Frame: Change from baseline to 12 weeks
Blood concentrations of gastric inhibitory peptide
Change from baseline to 12 weeks
Hormonal regulation of energy balance
Time Frame: Change from baseline to 12 weeks
Blood concentrations of cortisol
Change from baseline to 12 weeks
Hormonal regulation of energy balance
Time Frame: Change from baseline to 12 weeks
Blood concentrations of leptin
Change from baseline to 12 weeks
Cardiorespiratory fitness
Time Frame: Change in VO2max from baseline to 12 weeks
VO2max
Change in VO2max from baseline to 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Candida J Rebello, PhD, RD, Pennington Biomedical Research Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

December 1, 2030

Study Completion (Estimated)

December 1, 2030

Study Registration Dates

First Submitted

May 8, 2026

First Submitted That Met QC Criteria

May 14, 2026

First Posted (Actual)

May 20, 2026

Study Record Updates

Last Update Posted (Actual)

May 20, 2026

Last Update Submitted That Met QC Criteria

May 14, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • PBRC-2025-060
  • 1R01AG092725-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

At this time, we do not have plans to share IPD. We may consider it after the study results have been publicly disseminated

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Body Composition

Clinical Trials on Structured nutrition plan + exercise

Subscribe